Good day, ladies and gentlemen, and welcome to the First Quarter 2012 Laboratory Corp of America Holdings Earnings Conference Call. My name is Keisha, and I'll be your coordinator for today. At this time, all participants …
LabCorp remains focused on its strategy despite weak traffic to doctors' offices.
By Chuck Carnevale : Whether a buy and hold investment strategy is a good idea or not, is one of the most hotly debated investing concepts. From our point of view, the best answer as to whether buy and hold is a good strategy or not is that it primarily depends on the specific company or companies
Feb 10 (Reuters) - Laboratory Corp of America Holdings' quarterly earnings beat Wall Street forecasts helped by lower costs, but sales fell short of expectations.
Feb 10 (Reuters) - Laboratory Corp of America Holdings reported higher-than-expected quarterly earnings on Friday and forecast revenue growth of 2 percent to 3.5 percent in 2012.
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2011 Laboratory Corp of America Holdings Earnings Conference Call. My name is Jeff, and I'll be your coordinator for today. At this time, all participants …
Deutsche Bank comments on the deal Laboratory Corp . of America ( LH +0.9% ) struck to buy Orchid Cellmark, saying its model already reflects the expected divestiture of Orchid's government …
… labs, and hospital based labs. The industry’s two largest companies are Quest Diagnostics ( DGX ) and Laboratory Corp . of America ( LH ). Other publicly traded, but significantly smaller, competitors include Bio-Reference Laboratories …
… face value $25; BB+ rated) and yielding 7%; there are risks but you can sleep just as well as Buffett. Laboratory Corp of America ( LH ) has been hit by temporary concerns about reduced billing and reduced Medicare reimbursements, but is …
Oct 20 (Reuters) - Laboratory Corp of America Holdings posted a third-quarter profit that edged past market estimates and raised its full-year earnings outlook.